Diagnostic markers of serious bacterial infections in infants aged 29 to 90 days

Objectives: The diagnosis of serious bacte-rial infection (SBI) is difficult due to a lack of clinical evidence. The purpose of this study was to determine which inflamma-tory markers can be used to detect SBI in febrile infants.

Methods: This retrospective cohort study included infants aged 29 to 90 days who visited a tertiary hospital emergency de-partment in Korea between July 2016 and June 2018. The diagnostic characteristics of the neutrophil-to-lymphocyte ratio (NLR), procalcitonin (PCT), C-reactive protein (CRP), white blood cell (WBC) count, and absolute neutrophil cell (ANC) count for detecting SBI were described. Their cutoff values were calculated based on receiver operating characteristic (ROC) curve analysis.

Results: Among 528 infants, 199 were finally enrolled. SBI was detected in 68 (34.2%) of these infants. The median val-ues of all investigated diagnostic markers were significantly higher in infants with SBI than the values in those without: WBC (12.72 vs. 9.91 k/μL), ANC (6.28 vs. 3.14 k/μL), CRP (26.6 vs. 2.8 mg/L), NLR (1.29 vs. 0.78), and PCT (0.5 vs. 0 ng/mL). The areas under the ROC curves for discriminating SBI were: 0.705 (95% confidence interval [CI], 0.629-0.781), 0.793 (95% CI, 0.731-0.856), 0.832 (95% CI, 0.775-0.889), 0.722 (95% CI, 0.651-0.792), and 0.695 (95% CI, 0.611-0.780) for WBC, ANC, CRP, NLR, and PCT, respectively. Using a cutoff value of 0.67 for NLR, the negative predictive value was 90.8% for identifying SBI. Conclusions: CRP was the best single dis-criminatory marker of SBI, while NLR was the best parameter for considering dis-charge.

bacterial infection; urinary tract infection; clinical marker; discharge plan-ning 

1. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med 2000;36:602-614.

2. Milcent K, Faesch S, Gras-Le Guen C, Dubos F, Poulalhon C, Badier I, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr 2016;170:62-69.

3. Wilson CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986;108:1-12.

4. Kadish HA, Loveridget B, Tobeyt J, Bolte RG, Corneli HM. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered? Clin Pediatr 2000;39:81-88.

5. Tintinalli JE, Stapczynski JS, John MO, et al. Tintinalli's Emergnecy Medicine. 18th ed. New York, NY: McGraw-Hill Education; 2016.

6. Hamiel U, Bahat H, Kozer E, Hamiel Y, Ziv-Baran T, Goldman M. Diagnostic markers of acute infections in infants aged 1 week to 3 months: a retrospective cohort study. BMJ Open 2018 Jan 24;8(1):e018092.

7. Cortese F, Scicchitano P, Gesualdo M, Filaninno A, Giorgi ED, Schettini F, et al. Early and late infections in newborns: where do we stand? A review. Pediatr Neonatol 2016;57:265-273.

8. Biondi EA, Byington CL. Evaluation and management of febrile, well-appearing young infants. Infect Dis Clin North Am 2015;29:575-585.

9. Olaciregui I, Hernandez U, Munoz JA, Emparanza JI, Landa JJ. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch Dis Child 2009;94:501-505.

10. Gomez B, Bressan S, Mintegi S, Dalt LD, Blazquez D, Olaciregui I, et al. Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics 2012;130:815-822.

11. Bilavsky E, Yarden‐Bilavsky H, Ashkenazi S, Amir J. C‐reactive protein as a marker of serious bacterial infections in hospitalized febrile infants. Acta Paediatr 2009;98:1776-1780.

12. Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile infants for the detection of serious bacte-rial infections. Pediatrics 2008;122:701-710.

13. Hubert-Dibon G, Danjou L, Feildel-Fournial C, Vrignaud B, Masson D, Launay E, et al. Procalcitonin and C-reactive protein may help to detect invasive bacterial infections in children who have fever without source. Acta Paediatr 2018;107:1262-1269.

14. Greenhow TL, Hung Y-Y, Herz AM, Losada E, Pantell RH. The changing epidemiology of serious bacterial infections in young in-fants. Pediatr Infect Dis J 2014;33:595-599.

15. Rushton HG. Urinary tract infections in children: epidemiology, evaluation, and management. Pediatr Clin North Am 1997;44:1133-1169.

16. Pantell RH, Newman TB, Bernzweig J, Bergman DA, Takayama JI, Segal M, et al. Management and outcomes of care of fever in early infancy. JAMA 2004;291:1203-1212.

17. Jaskiewicz JA, McCarthy CA, Richardson AC, White KC, Fisher DJ, Powell KR, et al. Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pedi-atrics 1994;94:390-396.

18. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med 1993;329:1437-1441.

19. Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992;120:22-27.